Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label Clinical Evaluation of PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease

NCT00307814 is registered in ClinicalTrials.gov with Ortho Biotech Products, L.P. as lead sponsor.

NCT NCT00307814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00307814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label Clinical Evaluation of PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease
Lead sponsor
Ortho Biotech Products, L.P.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2002
Completion date
January 31, 2004
Enrollment
519 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chronic renal insufficiency